01.002 RWE TNT JULY 2022 G 21-07-2022

NICE formally adopts plan for real-world evidence utilisation

  • Last year, a plan to use a broader range of evidence was formally adopted by NICE
  • By using patient records and real-world evidence (such as registries and clinical audits), NICE anticipate improved guidance and sped-up recommendation updates
  • While this is intended primarily for health and social care system guidance, it may also be extended to health technology appraisalsts
Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at